Seres Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Seres Therapeutics, Inc. is a microbiome therapeutics company developing bacterial consortia treatments for diseases including C. difficile infection and ulcerative colitis.
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. is a microbiome therapeutics company developing bacterial consortia treatments for diseases including C. difficile infection and ulcerative colitis.